EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis

FRA:EWL • US28176E1082

65.52 EUR
-1.11 (-1.67%)
Last: Feb 16, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall EWL gets a fundamental rating of 6 out of 10. We evaluated EWL against 67 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making EWL a very profitable company, without any liquidiy or solvency issues. EWL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • EWL had positive earnings in the past year.
  • EWL had a positive operating cash flow in the past year.
  • EWL had positive earnings in 4 of the past 5 years.
  • EWL had a positive operating cash flow in 4 of the past 5 years.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

  • With an excellent Return On Assets value of 10.31%, EWL belongs to the best of the industry, outperforming 88.06% of the companies in the same industry.
  • EWL has a better Return On Equity (13.40%) than 76.12% of its industry peers.
  • EWL has a Return On Invested Capital of 9.83%. This is in the better half of the industry: EWL outperforms 79.10% of its industry peers.
  • EWL had an Average Return On Invested Capital over the past 3 years of 12.44%. This is above the industry average of 9.66%.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 9.83%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

  • EWL has a Profit Margin of 23.25%. This is amongst the best in the industry. EWL outperforms 91.04% of its industry peers.
  • EWL's Profit Margin has improved in the last couple of years.
  • The Operating Margin of EWL (27.73%) is better than 95.52% of its industry peers.
  • In the last couple of years the Operating Margin of EWL has remained more or less at the same level.
  • The Gross Margin of EWL (78.19%) is better than 91.04% of its industry peers.
  • EWL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EWL is still creating some value.
  • EWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • EWL has an Altman-Z score of 11.57. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
  • EWL has a better Altman-Z score (11.57) than 94.03% of its industry peers.
  • EWL has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
  • EWL has a better Debt to FCF ratio (0.75) than 89.55% of its industry peers.
  • A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
  • EWL has a Debt to Equity ratio of 0.06. This is amongst the best in the industry. EWL outperforms 83.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 11.57
ROIC/WACC0.99
WACC9.93%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

  • EWL has a Current Ratio of 4.00. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.00, EWL belongs to the top of the industry, outperforming 91.04% of the companies in the same industry.
  • EWL has a Quick Ratio of 3.29. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
  • EWL has a better Quick ratio (3.29) than 91.04% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for EWL have decreased by -2.29% in the last year.
  • The Earnings Per Share has been growing slightly by 6.67% on average over the past years.
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.26%

3.2 Future

  • EWL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.79% yearly.
  • EWL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.72% yearly.
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue Next Year9.73%
Revenue Next 2Y9.81%
Revenue Next 3Y9.8%
Revenue Next 5Y9.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 30.33, the valuation of EWL can be described as expensive.
  • EWL's Price/Earnings ratio is in line with the industry average.
  • When comparing the Price/Earnings ratio of EWL to the average of the S&P500 Index (27.16), we can say EWL is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 26.06, EWL can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EWL indicates a slightly more expensive valuation: EWL is more expensive than 61.19% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.10. EWL is around the same levels.
Industry RankSector Rank
PE 30.33
Fwd PE 26.06
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 62.69% of the companies in the same industry are cheaper than EWL, based on the Enterprise Value to EBITDA ratio.
  • EWL's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 56.23
EV/EBITDA 22.68
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EWL does not grow enough to justify the current Price/Earnings ratio.
  • EWL has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as EWL's earnings are expected to grow with 13.01% in the coming years.
PEG (NY)1.88
PEG (5Y)4.55
EPS Next 2Y13.34%
EPS Next 3Y13.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for EWL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EDWARDS LIFESCIENCES CORP

FRA:EWL (2/16/2026, 7:00:00 PM)

65.52

-1.11 (-1.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)04-21
Inst Owners89.94%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap38.02B
Revenue(TTM)N/A
Net Income(TTM)1.37B
Analysts79.53
Price Target82.86 (26.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)1.43%
PT rev (3m)7.16%
EPS NQ rev (1m)-0.25%
EPS NQ rev (3m)-0.06%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)0.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.38%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 30.33
Fwd PE 26.06
P/S 7.64
P/FCF 56.23
P/OCF 44.22
P/B 4.41
P/tB 6.15
EV/EBITDA 22.68
EPS(TTM)2.16
EY3.3%
EPS(NY)2.51
Fwd EY3.84%
FCF(TTM)1.17
FCFY1.78%
OCF(TTM)1.48
OCFY2.26%
SpS8.57
BVpS14.87
TBVpS10.65
PEG (NY)1.88
PEG (5Y)4.55
Graham Number26.88
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 9.83%
ROICexc 14.65%
ROICexgc 23.24%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 11.57
F-Score6
WACC9.93%
ROIC/WACC0.99
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
EPS Next Y16.14%
EPS Next 2Y13.34%
EPS Next 3Y13.01%
EPS Next 5Y12.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.26%
Revenue Next Year9.73%
Revenue Next 2Y9.81%
Revenue Next 3Y9.8%
Revenue Next 5Y9.72%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year13.12%
EBIT Next 3Y12.54%
EBIT Next 5Y12.98%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%

EDWARDS LIFESCIENCES CORP / EWL.DE FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 6 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 7 / 10.


What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 30.33 and the Price/Book (PB) ratio is 4.41.